Traphaco (TRA)

Traphaco Joint Stock Company (TRA) is founded in 1999 and located in Hanoi, it is part of the Basic Chemical Manufacturing Industry. It has 1,460 total employees across all of its locations and generates $82.08 million in sales (USD). There are 64 companies in the corporate family.

Traphaco is in the lead in the market of hepatobiliary drugs with popular products like Boganic, Cebraton, Hoat Huyet Duong Nao, and Tottri. The company is developing modern medicine products by investing in smart factories with good performance and showing positive prospects for growth. In the long term, the strong development of modern medicine will help Traphaco maintain the growth of revenue and profit. Once the smart factories are put into operation and upgraded to EU-GMP standards, Traphaco can participate in bidding packages of Group 1 and 2 in the ETC channel with better revenue scale and profit margin.

During the COVID-19 outbreak, Traphaco has quickly set up online consultancy departments, launched its e-commerce website, while providing 24/7 online support, offering consultancy and transactions on digital platforms, as well as supporting customers with door-to-door delivery.

Traphaco’s DMS has generated value for customers through optimising product access and user experience, while enhancing the performance of its distribution network. Currently, Traphaco is using DMS to manage more than 28,000 pharmacy customers as a distribution partner for many international corporations and pharmaceutical companies such as Kobayashi Pharmaceutical (Japan), Natural Factors Group (Canada), and PURE Sports Nutrition (New Zealand).

2007 - 2011